Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

The New York Times – Business:

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.

This post first appeared in The New York Times – Business. Read the original article.